An internal standard for the quantification of ezetimibe
Related Products
Unlabeled Version(s)
16331Ezetimibe
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Ezetimibe-d4

Item No. 25044

Technical Information
Formal Name
(3R,4S)-1-(4-fluorophenyl-2,3,5,6-d4)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
CAS Number
1093659-89-2
Synonyms
  • Ezetrol-d4
Molecular Formula
C24H17D4F2NO3
Formula Weight
Purity
≥99% deuterated forms (d1-d4)
Formulation
A solid
DMF: SolubleDMSO: SolubleEthanol: SolubleMethanol: Soluble
SMILES
OC(C=C1)=CC=C1[C@@H]2[C@@H](CC[C@H](O)C3=C([2H])C([2H])=C(F)C([2H])=C3[2H])C(N2C4=CC=C(F)C=C4)=O
InChi Code
InChI=1S/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2/t21-,22+,23-/m1/s1/i1D,2D,5D,6D
InChi Key
OLNTVTPDXPETLC-GMASCKFGSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Ezetimibe-d4 is intended for use as an internal standard for the quantification of ezetimibe (Item No. 16331) by GC- or LC-MS. Ezetimibe inhibits intestinal cholesterol absorption by preventing cholesterol uptake by the Niemann-Pick C1-like 1 (NPC1L1) protein, a cholesterol transporter located in the apical membrane of enterocytes.1,2 Upon oral administration ezetimibe undergoes rapid glucuronidation in the intestine where its glucuronide binds NPC1L1.1,2 Ezetimibe exhibits ED50 values of 0.0005-0.05 mg/kg in various animal models, selectively blocking cholesterol absorption without inhibiting pancreatic lipolytic enzyme activities in the intestinal lumen, affecting bile acid micelle solubilization of cholesterol, or interfering with the absorption of triglycerides, fatty acids, or bile acids.1,3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wang, D.Q. Regulation of intestinal cholesterol absorption. Annu. Rev. Physiol. 69, 221-248 (2007).

    2. Garcia-Calvo, M., Lisnock, J., Bull, H.G., et alThe target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc. Natl. Acad. Sci. USA 102(23), 8132-8137 (2005).

    3. Sudhop, T., and von Bergmann, K. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Drugs 62(16), 2333-2347 (2002).